Deep phenotyping of an international series of patients with late‐onset dysferlinopathy
暂无分享,去创建一个
G. Bassez | T. Maisonobe | F. Leturcq | Y. Péréon | P. Laforêt | B. Eymard | T. Stojkovic | A. Béhin | T. Kuntzer | T. Evangelista | S. Gorokhova | M. Krahn | V. Straub | A. Nadaj-Pakleza | S. Attarian | E. Salort-Campana | G. Solé | G. Querin | G. Fernández-Eulate | A. Bédat-Millet | J. Graveleau | M. Spinazzi | M. Masingue | Philippe Merle | U. Moore | S. Leonard-Louis | Leosnard Feasson
[1] Y. Hong,et al. Null variants in DYSF result in earlier symptom onset , 2020, Clinical genetics.
[2] G. Comi,et al. New genotype-phenotype correlations in a large European cohort of patients with sarcoglycanopathy. , 2020, Brain : a journal of neurology.
[3] T. Niihori,et al. The genetic profile of dysferlinopathy in a cohort of 209 cases: Genotype–phenotype relationship and a hotspot on the inner DysF domain , 2020, Human mutation.
[4] S. Thoms,et al. Functions of Vertebrate Ferlins , 2020, Cells.
[5] Christopher A. Lazarski,et al. Fibroadipogenic progenitors are responsible for muscle loss in limb girdle muscular dystrophy 2B , 2019, Nature Communications.
[6] H. Goebel,et al. 1st ENMC European meeting: The EURO-NMD pathology working group Recommended Standards for Muscle Pathology Amsterdam, The Netherlands, 7 December 2018 , 2019, Neuromuscular Disorders.
[7] J. Matsumoto,et al. Camptocormia: Etiology, diagnosis, and treatment response , 2018 .
[8] H. Otero,et al. Muscle MRI in patients with dysferlinopathy: pattern recognition and implications for clinical trials , 2018, Journal of Neurology, Neurosurgery, and Psychiatry.
[9] J. Jaiswal,et al. Annexin A2 links poor myofiber repair with inflammation and adipogenic replacement of the injured muscle , 2017, Human molecular genetics.
[10] C. Angelini,et al. Progress and challenges in diagnosis of dysferlinopathy , 2016, Muscle & nerve.
[11] J. Bevilacqua,et al. Dysferlin function in skeletal muscle: Possible pathological mechanisms and therapeutical targets in dysferlinopathies , 2016, Experimental Neurology.
[12] T. Hortobágyi,et al. Late onset dysferlinopathy mimicking treatment resistant polymyositis. , 2016, Joint, bone, spine : revue du rhumatisme.
[13] M. Milone,et al. Camptocormia as presenting manifestation of a spectrum of myopathic disorders , 2015, Muscle & nerve.
[14] C. Spurney,et al. Inhibition of inflammation with celastrol fails to improve muscle function in dysferlin-deficient A/J mice , 2015, Journal of the Neurological Sciences.
[15] Guixiu Shi,et al. Late-onset dysferlinopathy presented as "liver enzyme" abnormalities: a technical note. , 2014, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.
[16] Y. Itoyama,et al. Clinical features and a mutation with late onset of limb girdle muscular dystrophy 2B , 2012, Journal of Neurology, Neurosurgery & Psychiatry.
[17] T. Partridge,et al. Myogenesis in dysferlin-deficient myoblasts is inhibited by an intrinsic inflammatory response , 2012, Neuromuscular Disorders.
[18] S. M. van der Maarel,et al. Comparison of Dysferlin Expression in Human Skeletal Muscle with That in Monocytes for the Diagnosis of Dysferlin Myopathy , 2011, PloS one.
[19] C. Angelini,et al. Diagnosis by protein analysis of dysferlinopathy in two patients mistaken as polymyositis , 2011, Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology.
[20] P. Cintas,et al. Bent spine syndrome (camptocormia): a retrospective study of 63 patients. , 2010, Joint, bone, spine : revue du rhumatisme.
[21] C. Béroud,et al. Analysis of the DYSF mutational spectrum in a large cohort of patients , 2009, Human mutation.
[22] K. Bushby,et al. Late onset in dysferlinopathy widens the clinical spectrum , 2008, Neuromuscular Disorders.
[23] T. Maisonobe,et al. Complete fatty degeneration of lumbar erector spinae muscles caused by a primary dysferlinopathy , 2008, Muscle & nerve.
[24] D. Figarella-Branger,et al. Phenotypic study in 40 patients with dysferlin gene mutations: high frequency of atypical phenotypes. , 2007, Archives of neurology.
[25] J. T. Dunnen,et al. AHNAK a novel component of the dysferlin protein complex, redistributes to the cytoplasm with dysferlin during skeletal muscle regeneration , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[26] N. Bresolin,et al. Mutation finding in patients with dysferlin deficiency and role of the dysferlin interacting proteins annexin A1 and A2 in muscular dystrophies , 2005, Human mutation.
[27] I. Nonaka,et al. Dysferlinopathy associated with rigid spine syndrome , 2004, Neuropathology : official journal of the Japanese Society of Neuropathology.
[28] Y. Itoyama,et al. Novel dysferlin mutations and characteristic muscle atrophy in late‐onset Miyoshi myopathy , 2004, Muscle & nerve.
[29] T. Rando,et al. Late‐onset distal muscular dystrophy affecting the posterior calves , 2003, Muscle & nerve.
[30] J. Beckmann,et al. Genomic organization of the dysferlin gene and novel mutations in Miyoshi myopathy , 2001, Neurology.
[31] K. Bushby,et al. Dysferlinopathy (LGMD2B): a 23-year follow-up study of 10 patients homozygous for the same frameshifting dysferlin mutations , 2001, Neuromuscular Disorders.
[32] M. Baiget,et al. Distal anterior compartment myopathy: A dysferlin mutation causing a new muscular dystrophy phenotype , 2001, Annals of neurology.
[33] K. Bushby,et al. The third human FER-1-like protein is highly similar to dysferlin. , 2000, Genomics.
[34] Pieter J. de Jong,et al. Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy , 1998, Nature Genetics.
[35] J. Beckmann,et al. A gene related to Caenorhabditis elegans spermatogenesis factor fer-1 is mutated in limb-girdle muscular dystrophy type 2B , 1998, Nature Genetics.
[36] R. Waterston,et al. Characterization of dystrophin in muscle-biopsy specimens from patients with Duchenne's or Becker's muscular dystrophy. , 1988, The New England journal of medicine.
[37] K. Bushby,et al. The clinical outcome study for dysferlinopathy : An international multicenter study , 2019 .
[38] J. Vissing,et al. Axial myopathy: an overlooked feature of muscle diseases. , 2016, Brain : a journal of neurology.
[39] Y. Itoyama,et al. Clinical features and a mutation with late onset of limb girdle muscular dystrophy 2 B , 2012 .
[40] A. Pestronk,et al. Assessment of disease progression in dysferlinopathy A 1-year cohort study , 2022 .